Topic
18 stories from Planck Standard. Latest: July 22, 2026.
In a UCSF and Imperial College London trial, a single 25-milligram dose of the psychedelic triggered a surge in 'brain entropy' within an hour and left measurable changes detectable a full month later, hinting at how it may loosen rigid thinking.
Democratic attorneys general say the administration is defying a court order by moving to terminate Parkland-era funding that pays for counselors and psychologists in schools nationwide at the end of July.
A new State of Child Health report finds children's health declining or stalled across every measure, with Britain now the worst-performing G7 nation for MMR vaccination.
Americans born in the 1960s and early 1970s report higher levels of loneliness and depression than earlier generations, while other wealthy nations see improvements.
In a randomized trial, adults who added a glass of 100% juice or a smoothie to their five-a-day reported lower depression scores after four weeks. The effect was small — and the study was industry-funded.
Researchers identified specific amygdala neurons whose imbalanced activity alone can trigger pathological behaviors, then successfully restored normal function.
New survey reveals nearly 20% of adolescents and young adults turn to artificial intelligence for support when feeling sad, angry, nervous or stressed, raising questions about digital mental health resources.
The president is pushing to accelerate research into psychedelics as mental health treatments, creating new investment opportunities alongside regulatory risks.
Health Secretary's call to restrict depression medications has sparked intense debate at annual psychiatric meeting, with some fearing patients will avoid treatment.
A major analysis found that people with anxiety disorders have significantly lower choline levels in their brains, potentially pointing toward new nutrition-based treatments.
Major policy shift accelerates development of psychedelic-based medicines for treatment-resistant depression, PTSD, and substance abuse disorders under new federal directive.
Breakthrough research reveals how Morganella morganii bacteria interacts with environmental pollutants to produce inflammation-causing molecules strongly linked to major depressive disorder.
Researchers pinpoint two specific cell types that behave differently in depression, offering new treatment targets.
Breakthrough study using donated brain tissue reveals cellular changes in neurons and immune cells, providing clearest biological evidence of depression's physical basis.
Researchers at McGill University have pinpointed two distinct cell types that function differently in people with depression, offering new targets for treatment.
The order eases restrictions on studying psilocybin, MDMA, LSD, and ibogaine and positions Texas to immediately launch a state-administered addiction treatment research program.
The president's order aims to accelerate research into compounds like psilocybin and ibogaine for treating severe depression and PTSD.
Mediterranean nation joins Australia and Spain in restricting teenage access to social platforms amid growing concerns over digital wellbeing.